Tronox Holdings plc (FRA:T5X)
Germany · Delayed Price · Currency is EUR 4.060
-0.660 (-13.98%)
Last updated: Jul 31, 2025
Blueprint Medicines Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | -9 - -5 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | -9 - -5 |
| - | 3,074 | 2,850 | 3,454 | 3,572 | 2,758 | Upgrade | |
Revenue Growth (YoY) | - | 7.86% | -17.49% | -3.30% | 29.51% | 4.39% | Upgrade |
Cost of Revenue | - | 2,551 | 2,380 | 2,622 | 2,677 | 2,137 | Upgrade |
Gross Profit | - | 523 | 470 | 832 | 895 | 621 | Upgrade |
Selling, General & Admin | - | 261 | 240 | 228 | 264 | 272 | Upgrade |
Research & Development | - | 14 | 12 | 12 | 13 | 12 | Upgrade |
Other Operating Expenses | - | 12 | 10 | - | - | - | Upgrade |
Operating Expenses | - | 296 | 272 | 273 | 313 | 320 | Upgrade |
Operating Income | - | 227 | 198 | 559 | 582 | 301 | Upgrade |
Interest Expense | - | -197 | -183 | -125 | -157 | -189 | Upgrade |
Interest & Investment Income | - | 10 | 18 | 9 | 7 | 8 | Upgrade |
Currency Exchange Gain (Loss) | - | 8 | 6 | -3 | 16 | 4 | Upgrade |
Other Non Operating Income (Expenses) | - | 28 | 8 | -26 | 9 | 8 | Upgrade |
EBT Excluding Unusual Items | - | 76 | 47 | 414 | 457 | 132 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -18 | -27 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -1 | - | - | - | Upgrade |
Legal Settlements | - | - | - | -85 | - | - | Upgrade |
Other Unusual Items | - | -3 | - | -21 | -65 | -2 | Upgrade |
Pretax Income | - | 73 | 46 | 308 | 374 | 114 | Upgrade |
Income Tax Expense | - | 126 | 243 | -192 | 71 | -881 | Upgrade |
Earnings From Continuing Operations | - | -53 | -197 | 500 | 303 | 995 | Upgrade |
Net Income to Company | - | -53 | -197 | 500 | 303 | 995 | Upgrade |
Minority Interest in Earnings | - | 4 | -3 | -3 | -17 | -26 | Upgrade |
Net Income | - | -49 | -200 | 497 | 286 | 969 | Upgrade |
Net Income to Common | - | -49 | -200 | 497 | 286 | 969 | Upgrade |
Net Income Growth | - | - | - | 73.78% | -70.48% | - | Upgrade |
Shares Outstanding (Basic) | - | 158 | 156 | 155 | 152 | 143 | Upgrade |
Shares Outstanding (Diluted) | - | 158 | 156 | 157 | 158 | 145 | Upgrade |
Shares Change (YoY) | - | 0.91% | -0.45% | -0.53% | 9.00% | 3.61% | Upgrade |
EPS (Basic) | - | -0.31 | -1.28 | 3.21 | 1.88 | 6.76 | Upgrade |
EPS (Diluted) | - | -0.31 | -1.28 | 3.16 | 1.81 | 6.69 | Upgrade |
EPS Growth | - | - | - | 74.59% | -72.95% | - | Upgrade |
Free Cash Flow | - | -79 | -87 | 170 | 468 | 160 | Upgrade |
Free Cash Flow Per Share | - | -0.50 | -0.56 | 1.08 | 2.96 | 1.10 | Upgrade |
Dividend Per Share | - | 0.500 | 0.500 | 0.500 | 0.360 | 0.280 | Upgrade |
Dividend Growth | - | - | - | 38.89% | 28.57% | 55.56% | Upgrade |
Gross Margin | - | 17.01% | 16.49% | 24.09% | 25.06% | 22.52% | Upgrade |
Operating Margin | - | 7.38% | 6.95% | 16.18% | 16.29% | 10.91% | Upgrade |
Profit Margin | - | -1.59% | -7.02% | 14.39% | 8.01% | 35.13% | Upgrade |
Free Cash Flow Margin | - | -2.57% | -3.05% | 4.92% | 13.10% | 5.80% | Upgrade |
EBITDA | - | 504 | 458 | 828 | 879 | 605 | Upgrade |
EBITDA Margin | - | 16.40% | 16.07% | 23.97% | 24.61% | 21.94% | Upgrade |
D&A For EBITDA | - | 277 | 260 | 269 | 297 | 304 | Upgrade |
EBIT | - | 227 | 198 | 559 | 582 | 301 | Upgrade |
EBIT Margin | - | 7.38% | 6.95% | 16.18% | 16.29% | 10.91% | Upgrade |
Effective Tax Rate | - | 172.60% | 528.26% | - | 18.98% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.